Concourse Financial Group Securities’s Entero Therapeutics ENTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 9033 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 9087 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 9096 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 9104 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 8991 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 8772 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 8555 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 8343 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 8030 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 8042 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 7872 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 7746 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 7609 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 7467 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 7207 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 6935 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6676 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 6470 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6252 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6098 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6010 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 5928 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 5776 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 5793 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 5688 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5603 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 5442 |
|